Clinical Trial Update: Nocturnal Transnasal Insufflation (nTNI) [NA]

View source ↗

Summary

Clinical trial update for Nocturnal Transnasal Insufflation (nTNI) in COPD patients with hypercapnia; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Hypercapnia

Snippet

Sponsor: Institut für Pneumologie Hagen Ambrock eV | Conditions: COPD, Hypercapnia | NA | Status: COMPLETED